卒中后早期强化 mobilization 14天内致死与非致死事件
AVERT试验的第三级分析评估卒中后14天内致死与非致死严重不良事件。2,104例患者随机接受超早期 mobilization(VEM)或常规护理(UC),VEM组14天死亡率经年龄和卒中严重度调整后显著增高(OR 1.76,95%CI 1.06-2.92,p=0.029),非致死性SAE无差异。
要点
- VEM组14天死亡48例,UC组32例,调整后OR 1.76(95%CI 1.06-2.92,p=0.029)。
- 卒中进展在VEM组更常见,非致死性SAE两组无差异。
- 探索性亚组显示脑出血和>80岁亚组死亡 odds 更高,但无显著交互作用。
核心结论
- 14天总病死率仅3.8%,但经年龄和卒中严重度调整后,高强度超早期 mobilization 较常规护理增加死亡率。
- 卒中进展在VEM组更常见。
- 非致死性严重不良事件两组无差异。
研究设计与样本
- AVERT为前瞻性、平行组、评估者盲法、随机国际临床试验。
- 纳入卒中发病24小时内缺血性或出血性患者,允许溶栓,排除严重病前残疾或合并症。
- 2,104例随机分VEM组(n=1,054)和UC组(n=1,050),中位年龄72岁(IQR 63-80),NIHSS 7(IQR 4-12)。
- 干预持续14天或至出院(若更短),主要早期安全结局为14天内致死性SAE。
主要发现
- 14天内VEM组死亡48例,UC组32例。
- 年龄和卒中严重度调整后死亡OR 1.76(95%CI 1.06-2.92,p=0.029)。
- 卒中进展在VEM组更常见。
- 非致死性SAE两组无差异。
- 探索性亚组分析显示脑出血和>80岁亚组死亡 odds 更高,但亚组与治疗交互作用无统计学意义。
关键数值与推荐
- 主要早期安全结局:14天内致死性SAE。
- 次要结局:非致死性SAE,分为神经性、制动相关和其他。
- mortality 影响采用二元 logistic 回归调整基线卒中严重度(NIHSS评分)和年龄。
- 证据等级:Class I,表明超早期 mobilization 增加卒中后14天死亡率。
临床怎么用
- 卒中后24小时内启动高强度超早期 mobilization 可能增加14天死亡风险,临床应避免常规采用。
- 对脑出血和>80岁患者尤需谨慎评估早期 mobilization 的风险与获益。
- 非致死性严重不良事件未见增加,但致死性风险升高提示需权衡早期活动强度。
局限性
- 原文未报告局限性相关内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This tertiary analysis from A Very Early Rehabilitation Trial (AVERT) examined fatal and nonfatal serious adverse events (SAEs) at 14 days. METHOD: AVERT was a prospective, parallel group, assessor blinded, randomized international clinical trial comparing mobility training commenced <24 hours poststroke, termed very early mobilization (VEM), to usual care (UC). Primary outcome was assessed at 3 months. Patients with ischemic or hemorrhagic stroke within 24 hours of onset were included. Treatment with thrombolytics was allowed. Patients with severe premorbid disability or comorbidities were excluded. Interventions continued for 14 days or hospital discharge if less. The primary early safety outcome was fatal SAEs within 14 days. Secondary outcomes were nonfatal SAEs classified as neurologic, immobility-related, and other. Mortality influences were assessed using binary logistic regression adjusted for baseline stroke severity (NIH Stroke Scale [NIHSS] score) and age. RESULTS: A total of 2,104 participants were randomized to VEM (n = 1,054) or UC (n = 1,050) with a median age of 72 years (interquartile range [IQR] 63-80) and NIHSS 7 (IQR 4-12). By 14 days, 48 had died in VEM, 32 in UC, age and stroke severity adjusted odds ratio of 1.76 (95% confidence interval 1.06-2.92, p = 0.029). Stroke progression was more common in VEM. Exploratory subgroup analyses showed higher odds of death in intracerebral hemorrhage and >80 years subgroups, but there was no significant treatment by subgroup interaction. No difference in nonfatal SAEs was found. CONCLUSION: While the overall case fatality at 14 days poststroke was only 3.8%, mortality adjusted for age and stroke severity was increased with high dose and intensive training compared to usual care. Stroke progression was more common in VEM. REGISTRATION: Australian New Zealand Clinical Trials Registry, ACTRN12606000185561. CLASSIFICATION OF EVIDENCE: This study provides Class I evidence that very early mobilization increases mortality at 14 days poststroke.
引用
- Bernhardt J, Borschmann K, Collier JM, et al. Fatal and Nonfatal Events Within 14 days After Early, Intensive Mobilization Poststroke. Neurology. 2021. PMID: 33144512. doi:10.1212/WNL.0000000000011106
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。